Research Article

[Retracted] The Relevance of Interventional Time and Clinical Outcomes in Patients with NSTEMI Based on the GRACE Score

Table 1

Baseline characteristics.

VariablesPopulation ()GRACE points ()GRACE scores 109–140 points ()GRACE points ()

Age (years)
Male, (%)945 (69.64)328 (79.41)369 (72.92)248 (56.62)
Medical history, (%)
 Hypertension917 (67.58)268 (64.89)347 (68.57)302 (68.95)0.374
 Diabetes mellitus460 (33.90)114 (27.60)163 (32.21)183 (41.78)
 Stroke312 (22.99)55 (13.31)119 (23.52)138 (31.51)
 Previous MI250 (18.42)54 (13.08)92 (18.18)104 (23.74)
Previous PCI219 (16.14)58 (14.04)90 (17.79)71 (16.21)0.308
 Previous CABG73 (5.38)13 (3.15)27 (5.34)33 (7.53)
 Current smokers790 (58.26)279 (67.72)303 (59.88)208 (47.49)
Laboratory characteristics
 LVEF (%)
 Serum creatinine (μmol/L)
 NT-proBNP (pg/mL)
 Hs-cTnT (ng/mL)
Treatment methods, (%)
 Conservative treatment472 (34.78)99 (23.97)158 (31.23)215 (49.09)
 PCI770 (56.74)286 (69.24)30 1(59.48)183 (41.78)
CABG115 (8.47)28 (6.78)47 (9.28)40 (9.13)0.332
Time from admission to intervention therapy
 <24 h, (%)91 (6.71)29 (7.02)28 (5.53)34 (7.76)0.375
 24–27 h, (%)110 (8.11)48 (11.62)42 (8.30)20 (4.57)
 >72 h, (%)509 (37.51)189 (45.76)208 (41.11)112 (25.57)
Extent of coronary artery disease, (%)
 0-Vessel22 (2.05)14 (3.77)4 (0.96)4 (1.41)
 1-Vessel177 (16.51)83 (22.37)69 (16.55)25 (8.80)
 2-Vessel245 (22.85)101 (27.22)99 (23.74)45 (15.85)
 3-Vessel623 (58.11)172 (46.36)242 (58.03)209 (73.59)
 LM disease, (%)165 (15.39)27 (7.28)62 (15.11)75 (26.41)
 ≥1 vessel occlusion, (%)464 (34.19)141 (34.14)176 (34.78)147 (33.56)0.925

CABG: coronary artery bypass surgery; LVEF: left ventricular ejection fraction; LM: left main trunk.